Bruker Corporation

WHO'M
ai
Digital Profiler. Simply click the AI button
CUSIP
116794108
SEDOL
2616137
CIK
0001109354
www.bruker.com
LEI: LEBZ6VLQ6I8XB1NHVY15
©
New: Infographics X-Lab
Bruker is a Member of Themefolio
          Nano-Technology          
FIGI: BBG000CL1FG7
BRKR
Bruker Corporation
GICS: - · Sector: Healthcare · Sub-Sector: Medical Devices
AI
PROFILER
NAME
Bruker Corporation
ISIN
US1167941087
TICKER
BRKR
MIC
XNAS
REUTERS
BRKR.OQ
BLOOMBERG
BRKR US
BUILD THEMEFOLIO SHARE IDEAS DISCUSS
LEVERAGE INVEST
Financial Intelligence
360° iHub Crowd iFeed ATH Tracker Index Tracker ETF TF Spicy2 X-Billboard
FOR INVESTORS
FOR TRADERS
Securities Trading Warrants
The X-News Explorer is the ultimate source of information for investors with an affinity for the stock market who want to get a quick and convenient overview of the current news situation of a listed company. Various newswire services are available to you here. If a news alert is displayed, you will find company news that may be of interest to you. This service is provided by BusinessWire.
Thu, 17.04.2025       Bruker
US1167941087

Bruker Corporation (Nasdaq: BRKR) today announced the launch of the nVista 2P miniature, two-photon microscope, a groundbreaking addition to the Inscopix product line for functional imaging of freely behaving animals. It leverages advanced two-photon fluorescence microscopy technology to enable high-resolution imaging at greater depths with 3D dat...
Read More
Bruker
Technical Analysis Termsheet Terminal
Permalink
Wed, 16.04.2025       Bruker
US1167941087

Bruker Corporation (NASDAQ: BRKR) today announced a majority investment in RECIPE Chemicals + Instruments GmbH, based in Munich, Germany. RECIPE is a leading European provider of vendor-agnostic therapeutic drug monitoring (TDM) and other clinical in vitro diagnostic kits for LC-MS/MS, HPLC, and ICP-MS assays. This press release features multimedi...
Read More
Bruker
Technical Analysis Termsheet Terminal
Permalink
Fri, 11.04.2025       Bruker
US1167941087

Bruker Corporation (Nasdaq: BRKR) today announced preliminary revenue for the first quarter ended March 31, 2025, in a range of $795 million to $800 million, comparing favorably to the Company’s earlier outlook and well ahead of consensus. This estimated range implies reported revenue growth of approximately 10% year-over-year, with low-double di...
Read More
Bruker
Technical Analysis Termsheet Terminal
Permalink
Fri, 11.04.2025       Bruker
US1167941087

At the ESCMID Global 2025 conference, Bruker´s Microbiology and Infection Diagnostics division is announcing the expansion of its microbiology solutions into Next-Generation Sequencing (NGS) applications, with new, research-use only NGS-based solutions in epidemiology and hospital acquired infection (HAI) tracing. This press release features multi...
Read More
Bruker
Technical Analysis Termsheet Terminal
Permalink
Mon, 07.04.2025       Bruker
US1167941087

At the Joint ENC-ISMAR Conference 2025, Bruker Corporation, the leading provider of Nuclear Magnetic Resonance (NMR) spectroscopy solutions, announced the successful development and testing of the world’s first high-resolution 1.3 GHz NMR spectrometer with a stable, standard-bore 54 mm superconducting magnet. This first-of-a-kind ultra-high field ...
Read More
Bruker
Technical Analysis Termsheet Terminal
Permalink
Mon, 07.04.2025       Bruker
US1167941087

At the Joint ENC-ISMAR Conference 2025, Bruker Corporation, the leading provider of Nuclear Magnetic Resonance (NMR) spectroscopy solutions, announced the launch of an innovative Fourier 80 multinuclear benchtop FT-NMR spectrometer, known as the ‘Multi-Talent’ configuration. This novel Fourier 80 ‘Multi-Talent’ system represents a major advancemen...
Read More
Bruker
Technical Analysis Termsheet Terminal
Permalink
Wed, 02.04.2025       Bruker
US1167941087

Bruker Corporation today announced the introduction of its groundbreaking dissolution Dynamic Nuclear Polarization (d-DNP) Polarizer at the 2025 Hyperpolarized Carbon-13 MRI Technology Development Workshop at the University of California San Francisco (UCSF) Hyperpolarized MRI Technology Resource Center. The first customer installation of this inn...
Read More
Bruker
Technical Analysis Termsheet Terminal
Permalink
Thu, 27.02.2025       Bruker
US1167941087

Bruker Corporation (Nasdaq: BRKR) today announces the launch of the new X4 POSEIDON™, a high-performance 3D X-ray microscope (XRM) using micro-Computed Tomography (microCT). This innovative benchtop XRM system offers advanced capabilities comparable to larger, floor-standing systems to make high-resolution 3D X-ray microscopy accessible for demand...
Read More
Bruker
Technical Analysis Termsheet Terminal
Permalink
Mon, 24.02.2025       Bruker
US1167941087

At the 21st Annual US HUPO Conference, Bruker Corporation (Nasdaq: BRKR) announces significant advances in 4D-Proteomics™ performance, software and applications for deeper biological insights. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250224096888/en/SCP-relevant 250 picogram samp...
Read More
Bruker
Technical Analysis Termsheet Terminal
Permalink
Fri, 21.02.2025       Bruker
US1167941087

Bruker Corporation (Nasdaq: BRKR) announced today that it will unveil significant advancements in spatial biology at the 2025 Advances in Genome Biology and Technology (AGBT) General Meeting. Bruker Spatial Biology will announce the following four innovations that underscore Bruker’s leading commitment to advancing spatial biology with pioneering,...
Read More
Bruker
Technical Analysis Termsheet Terminal
Permalink
We are different
OPEN FINANCIAL
DATA & KNOWLEDGE HUB
We make the difference
Information on product placements

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S